Author

Muraoka Suguru

h-index 0 View on Semantic Scholar

We have 1 of 1 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Jul 2026

KRAS-Targeted Therapy in Non–Small Cell Lung Cancer: Current Standards, Resistance Mechanisms, and Emerging Therapeutic Strategies

Direct KRAS inhibition has transformed KRAS G12C–mutated NSCLC from a previously undruggable subtype into a targetable disease, but durable disease control remains an unmet need.

Kohei Eguchi, Yukito Kajita, Muraoka Suguru et al. · Journal of Clinical Question · 0 citations